Posted on 04/29/2020 6:53:28 AM PDT by 1Old Pro
Remdesivir is widely considered to be a front-runner among the investigational therapies being tested as treatments for COVID-19
Gilead Sciences Inc. (GILD) said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study.
The early findings set the stage for the closely watched drug to move toward a possible emergency use authorization or approval from the U.S. Food and Drug Administration. The drug is currently being used on an expanded use or compassionate use basis.
Shares of Gilead (GILD) gained 5.7% in trading on Wednesday following the news announcement.
Remdesivir is widely considered to be a front-runner among the investigational therapies being tested as treatments for infections caused by the novel coronavirus, which has sickened more than three million people and killed at least 217,000. There are no proven treatments or vaccines.
Gilead's stock has had a turbulent few weeks (http://www.marketwatch.com/story/gileads-remdesivir-takes-center-stage- for-now-but-hiv-drugs-make-up-majority-of-sales-2020-04-24) as media outlets have reported on leaked data, both positive and negative, from some of the many clinical trials under way evaluating the drug.
Gilead said an open-label Phase 3 trial (https://clinicaltrials.gov/ct2/show/record/NCT04292899?cond=covid&draw=2) testing the therapy in 6,000 severely ill patients found that those taking a 5-day or 10-day course of treatment led to similar results. At least 52% of participants taking either dosing regimen were discharged from the hospital after 14 days of treatment, and at least 53% of those patients were reported as reaching "clinical recovery."
"Multiple concurrent studies are helping inform whether remdesivir is a safe and effective treatment for COVID-19," Gilead chief medical officer Merdad Parsey said in a statement. "The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir."
Minutes before this top-line data was released, Gilead said that a National Institute of Allergy and Infectious Diseases clinical trial (https://clinicaltrials.gov/ct2/show/record/NCT04280705) evaluating remdesivir in hospitalized COVID-19 patients met the study's primary endpoint. The federal agency is expected to provide additional information about that trial, Gilead said. The primary outcome in this trial is recovery by 29 days of treatment, according to the study's listing on ClinicalTrials.gov.
Gilead's stock has gained 21.0% year-to-date, while the S&P 500 is down 11.3%.
There is a balm in Gilead...
What is the treatment for hoax?
“In February 2020, the [Wuhan Institute of Virology] applied for a patent in China for the use of remdesivir, an experimental drug owned by Gilead Sciences, which the Institute found inhibited the virus in vitro;[25] in a move that raised concerns regarding intellectual property rights.[26]
“The WIV said it would not exercise its new Chinese patent rights “if relevant foreign companies intend to contribute to the prevention and control of China’s epidemic”.[27]
https://en.wikipedia.org/wiki/Wuhan_Institute_of_Virology#2019–20_coronavirus_pandemic
How are we supposed to "follow the science" ?
Chinese stealing property rights, that's a new one /s
Probably because of the corrupt media?
And then extorting Gilead. Presumably for free Remdesivir shipments.
They’d make Democrat Congressmen.
This is a super expensive treatment. You have to go to the hospital as it is given intravenously.
Sure would like to know who is buying blocks of Gilead.
Like a cleansing Trump referred to?
Gilead produced the vaccine For Hep C. The good news is that I had Hep C and took Harvoni and am cured. The bad news is that I have a cancerous mass on my liver. I hope they are successful with their development of treatment drugs. I look at life a little differently now. I’m past fear.
If you torture the data long enough ....
Keep in mind this message comes to you from the ‘pump and dump’ puppets at Dow Jones who are obliged to make their Brokerage Firm masters happy.
Gilead went from $60 to $85 based upon the hyoe from Dow Jones and the Brokerage Firms.
That was a report form China. They lied.
“”””Sure would like to know who is buying blocks of Gilead.”””
For every buyer there is a seller.
It would be far more interesting to know who is SELLING Gilead.
“The only truth I’m coming to realize is that “science” has become an over-politicized mess that is more interested in shaping public opinion than in finding the truth. Scientists do not appear to be too far removed from journalists these days.”
As a famous person once said, politics trumps everything!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.